0001651431-17-000001.txt : 20170216 0001651431-17-000001.hdr.sgml : 20170216 20170216160815 ACCESSION NUMBER: 0001651431-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170216 DATE AS OF CHANGE: 20170216 EFFECTIVENESS DATE: 20170216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001651431 IRS NUMBER: 364813934 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-246410 FILM NUMBER: 17617986 BUSINESS ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 978-503-2124 MAIL ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0707 D/A LIVE 0001651431 Checkmate Pharmaceuticals, Inc. 1 BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 978-503-2124 DELAWARE None None Corporation true 2015 Arthur A. Krieg 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Michael Powell 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Corey Goodman 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Chuck Abdalian 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Biotechnology Decline to Disclose 06b true 0001651431-15-000001 2015-08-11 false true false 0 25000000 25000000 0 false 2 0 0 0 false Checkmate Pharmaceuticals, Inc. /s/ Chuck Abdalian Chuck Abdalian Chief Financial Officer 2017-02-16